63.92% 0.1088

Aptose Biosciences Inc (APTO)

Panoramica Notizia Cronologia dei prezzi Financials Perché APTO Giù? Forum Previsione Frazionamento azionario

Aptose Biosciences Inc Azioni (APTO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	19.52% 9.76	12.13	11.68	14.45	14.10
Nonoperating Income/Loss	30.23% 0.12	0.172	0.234	0.323	0.42
Income/Loss From Continuing Operations Before Tax	104.18% 0.50	-11.96	-11.45	-14.13	-13.68
Income/Loss From Continuing Operations After Tax	104.18% 0.50	-11.96	-11.45	-14.13	-13.68
Net Income/Loss	19.36% -9.64	-11.96	-11.45	-14.13	-13.68
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,508% 13.13	0.364	6.495	6.234	92.56
Diluted Average Shares	3,508% 13.13	0.364	6.495	6.234	92.56
Basic Earnings Per Share	53.50% -0.73	-1.57	-1.76	-2.27	-2.25
Diluted Earnings Per Share	53.50% -0.73	-1.57	-1.76	-2.27	-2.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%